Follow PharmaTimes: News RSS, filter it, and define how you want to receive the news (via Email, RSS, Telegram, WhatsApp etc.) https://follow.it/pharmatimes-news-rss Fri, 27 Jan 2023 20:38:27 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMo-idHZdgVUKYeLGixeGJZp Clinical study is researching patients with diabetes and advanced chronic kidney disease]]> Fri, 27 Jan 2023 15:35:46 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMo-idHZdgVUKYeLGixeGJZp https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMo-idHZdgVUKRKeetMRuZbW Therapy involves patients with paediatric-onset hypophosphatasia – a rare bone disease]]> Fri, 27 Jan 2023 15:21:52 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMo-idHZdgVUKRKeetMRuZbW https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpNbTSB4YXaUGnhpmeYcemU Trial will evaluate efficacy of anti-netrin-1 antibody candidate NP137 in combination with Atezo-bev]]> Thu, 26 Jan 2023 15:00:08 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpNbTSB4YXaUGnhpmeYcemU https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMr_GKTGjNXhh--bbeigX9oC Treatment involves adult patients with relapsed or refractory diffuse large B-cell lymphoma]]> Thu, 26 Jan 2023 14:50:44 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMr_GKTGjNXhh--bbeigX9oC https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoect-AfXaXW68qfTAM-Smm Data shows that STC-15 exhibits efficacy as a single agent and in combination with venetoclax]]> Wed, 25 Jan 2023 15:09:30 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoect-AfXaXW68qfTAM-Smm https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpp7SUbhAKoYhKeetMRuZbW New enteric-coated tablet formulation will now replace the previous prototype capsule]]> Wed, 25 Jan 2023 15:05:14 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpp7SUbhAKoYhKeetMRuZbW https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMq1lzQfaoBY-mW0GqTRQSgk Amber-UI presents a significant opportunity to treat urge and mixed urinary incontinence]]> Tue, 24 Jan 2023 13:29:13 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMq1lzQfaoBY-mW0GqTRQSgk https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMq1lzQfaoBY-s4HQhe4ZUzd Therapy involves renal transplant patients requiring treatment of BK polyomavirus infection]]> Tue, 24 Jan 2023 13:23:46 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMq1lzQfaoBY-s4HQhe4ZUzd https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMop6LH-mTFcmgaB2UxGNFpJ Treatment is a maintenance therapy for certain patients with acute myeloid leukaemia]]> Mon, 23 Jan 2023 14:02:59 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMop6LH-mTFcmgaB2UxGNFpJ https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpuWgqffNvUAGw5Ur-z5Bww During the research SonoTran is being evaluated in patients with metastatic colorectal cancer]]> Mon, 23 Jan 2023 13:58:04 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpuWgqffNvUAGw5Ur-z5Bww https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMp_TULPORg8w9KEpFgimKzx Therapy involves patients living with relapsed or refractory multiple myeloma]]> Fri, 20 Jan 2023 14:10:38 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMp_TULPORg8w9KEpFgimKzx https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMp_TULPORg8wy3FFO_xyF25 The NICE recommendation followed data from clinical trials and real-world evidence]]> Fri, 20 Jan 2023 14:07:56 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMp_TULPORg8wy3FFO_xyF25 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMr89WRdOjepji1Ly282xAAw Therapy is among the first to receive a positive draft recommendation under streamlined pilot process]]> Thu, 19 Jan 2023 13:31:39 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMr89WRdOjepji1Ly282xAAw https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMr89WRdOjepjlyOSYGFl6uu The new funding package will be used to progress NeoPhore’s expanding pipeline of therapies]]> Thu, 19 Jan 2023 13:27:48 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMr89WRdOjepjlyOSYGFl6uu https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMo9dxwQde40rFyOSYGFl6uu Unrelenting pressure caused by strikes, flu and COVID-19 may be keeping NHS in vicious cycle]]> Wed, 18 Jan 2023 15:23:24 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMo9dxwQde40rFyOSYGFl6uu https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMo9dxwQde40rASngkwrdsok Therapy is the first oral MET inhibitor treatment option for certain advanced NSCLC adult patients]]> Wed, 18 Jan 2023 15:21:22 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMo9dxwQde40rASngkwrdsok https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqRETndcolucWFk24e89-qg Biosimilar gains MHRA marketing authorisation for use throughout Britain]]> Tue, 17 Jan 2023 15:20:03 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqRETndcolucWFk24e89-qg https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqq-t9-6F9uEkoy9CZgXDJO Industry-first cancer screening technology boosted by biomedical grant funding]]> Tue, 17 Jan 2023 14:53:00 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqq-t9-6F9uEkoy9CZgXDJO https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoFN1w-H_Bx_WnhpmeYcemU MHRA approval relates to the company’s midlands-based drug development facilities]]> Mon, 16 Jan 2023 14:26:26 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoFN1w-H_Bx_WnhpmeYcemU https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoFN1w-H_Bx_cfGo0LrnZNO Major industry names depart leaving UK pricing deal in serious jeopardy]]> Mon, 16 Jan 2023 14:23:18 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoFN1w-H_Bx_cfGo0LrnZNO